Nanopath
PrivateLast Round
Grant
May 21, 2024
Total Funding Raised
$14M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Nanopath is a diagnostic equipment company that has developed a molecular diagnostic platform designed to enable point-of-care disease diagnosis.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Precision Medicine, Sensors
Business Model
B2B
Customer Profile
Hardware Sales, Usage-Based SaaS, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nanopath Comparables
Compare Nanopath with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Rover Diagnostics | 85% | |
| AltraTech Limited | 78% | |
| GRIP Molecular Technologies | 78% |
Nanopath Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | May 21, 2024 | ||||
| Series A | Aug 9, 2022 |
Key People
Founding team and executive leadership
Nanopath Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| SV Health Investors | Series A |
| NIH RADx | Grant |
| GingerBread Capital | Series A |
| Norwest Venture Partners | Series A |
| Alumni Ventures | Series A |
| Alumni Ventures | Series A |
| National Science Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 27, 2026
Open roles increased to 45, 3x the trailing average.
- Jul 13, 2026
Open roles increased to 13, 42% of headcount.
Recent news
Latest coverage and updates
- is_developingSep 26, 2026
Nanopath Inc. is developing FreshGuard.
Nanopath Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Nanopath's valuation, stock price, and market status.
Is Nanopath a public or private company?
Nanopath is a private company.
What is the current stock price of Nanopath?
Nanopath is a private company with no public stock price. No recent secondary market data is available.
How much is Nanopath worth (valuation)?
Valuation information for Nanopath is not publicly available.
Can I buy Nanopath stock?
Nanopath shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Nanopath's last funding round?
Nanopath's most recent funding round was Grant on May 21, 2024.
Who are the main investors in Nanopath?
Key investors in Nanopath include SV Health Investors, Norwest Venture Partners.
Will Nanopath IPO soon?
No public IPO plans have been announced for Nanopath.
How can I track Nanopath secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Nanopath's secondary market activity and sign up for updates.